Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Elisabeth-TweeSteden Ziekenhuis

Verifiedinfo

The Netherlands Hilvarenbeekse Weg 60, 5022 Tilburg, The Netherlands

  • 2 trials recruiting
  • Rheumatoid arthritis · Brain abscess · Multiple sclerosis
  • Adult patients

About Specializations

Elisabeth-TweeSteden Ziekenhuis in Tilburg, The Netherlands specialises in clinical trials of conditions such as Rheumatoid arthritis, Brain abscess, Multiple sclerosis, and other specialisations. This site conducts important research.

Main research areas of the site

Neurology and Multiple Sclerosis

The medical center is at the forefront of neurology research, with a particular focus on Multiple Sclerosis (MS). The institution is dedicated to exploring innovative treatment strategies that enhance patient outcomes and quality of life.

  • Personalized Treatment Approaches
  • Extended Interval Dosing
  • Real-life Cohort Studies

Through its pioneering work, the center is advancing the understanding of MS and developing personalized therapies that aim to improve the safety and efficacy of existing treatments.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Hilvarenbeekse Weg 605022 TilburgThe Netherlands
Open in maps ↗
Recruiting now
2 trials
Conditions studied
3
Partner status
Verified

More sites in TilburgThe Netherlands

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Rheumatoid arthritis

Recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Sint Maartenskliniek

Brain abscess

Recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Aalborg University Hospital

Multiple sclerosis

Not recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Natalizumab
  • Sponsor:Amsterdam UMC Stichting
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.